To view this email as a web page, click here.

Managing Cytokine Release Syndrome in Patients on CAR T-Cell Therapy

During the ASCO Annual Meeting, we discuss the assessment and management of cytokine release syndrome in patients with cancer with Elizabeth Shpall, MD.

Prolong Adjuvant Aromatase Inhibitor Therapy in Breast Cancer?

Cancer Network spoke with Richard Gray, MSc, about the effects of prolonging adjuvant aromatase inhibitor therapy has on breast cancer patients.

IN CASE YOU MISSED IT

Drug Combo Granted Priority Review for Untreated Follicular Lymphoma

The FDA has granted Priority Review to Celgene’s application for lenalidomide in combination with rituximab for previously untreated follicular lymphoma.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.